Clarification on scope of the NEWCO Hello Dr. XXXX
It is expected that all rights to develop, license and manufacture MCC will be granted to Bioniche Therapeutics Corp., beginning with the Urocidin-related rights.
Oncocidin is an animal health product that we plan to manufacture in our Montreal facility for Bioniche Animal Health. This arrangement will be accommodated with the new structure.
Sincerely,
Jennifer
Jennifer Shea
Vice-President, Communications, Investor & Government Relations
Bioniche Life Sciences Inc.
P.O. Box 1570, 231 Dundas St. E.
Belleville, Ontario
Canada K8N 5J2
Phone: 613-966-8058 ext. 1250
Mobile: 613-391-2097
Fax: 613-966-4177